NASDAQ:DRIO DarioHealth (DRIO) Stock Price, News & Analysis $0.62 -0.03 (-5.00%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$0.65 +0.03 (+4.17%) As of 03/28/2025 06:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About DarioHealth Stock (NASDAQ:DRIO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get DarioHealth alerts:Sign Up Key Stats Today's Range$0.60▼$0.6650-Day Range$0.60▼$0.7552-Week Range$0.56▼$1.93Volume192,692 shsAverage Volume265,554 shsMarket Capitalization$25.90 millionP/E RatioN/ADividend YieldN/APrice Target$1.50Consensus RatingModerate Buy Company OverviewDarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.Read More… Remove Ads DarioHealth Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks53rd Percentile Overall ScoreDRIO MarketRank™: DarioHealth scored higher than 53% of companies evaluated by MarketBeat, and ranked 490th out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.3 / 5Analyst RatingModerate Buy Consensus RatingDarioHealth has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Amount of Analyst CoverageDarioHealth has only been the subject of 2 research reports in the past 90 days.Read more about DarioHealth's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for DarioHealth are expected to grow in the coming year, from ($1.18) to ($1.06) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of DarioHealth is -0.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of DarioHealth is -0.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioDarioHealth has a P/B Ratio of 0.29. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about DarioHealth's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted8.92% of the float of DarioHealth has been sold short.Short Interest Ratio / Days to CoverDarioHealth has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in DarioHealth has recently decreased by 1.55%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldDarioHealth does not currently pay a dividend.Dividend GrowthDarioHealth does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted8.92% of the float of DarioHealth has been sold short.Short Interest Ratio / Days to CoverDarioHealth has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in DarioHealth has recently decreased by 1.55%, indicating that investor sentiment is improving. News and Social Media3.0 / 5News Sentiment1.45 News SentimentDarioHealth has a news sentiment score of 1.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.80 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for DarioHealth this week, compared to 1 article on an average week.Search InterestOnly 2 people have searched for DRIO on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, DarioHealth insiders have not sold or bought any company stock.Percentage Held by Insiders10.90% of the stock of DarioHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 33.39% of the stock of DarioHealth is held by institutions.Read more about DarioHealth's insider trading history. Receive DRIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DarioHealth and its competitors with MarketBeat's FREE daily newsletter. Email Address DRIO Stock News HeadlinesMarket Alert: Hinge Health's Multi-Billion Dollar Expected IPO Highlights 600% Valuation Opportunity for DarioHealthMarch 24, 2025 | businesswire.comDarioHealth granted extension to regain Nasdaq complianceMarch 21, 2025 | investing.comWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Oracle"—known for spotting Apple, Amazon, and Google early—has identified a firm with patented tech that could become essential to every major AI player. He shares the name and ticker in this free video—but warns the opportunity could vanish once it hits the mainstream.March 30, 2025 | InvestorPlace (Ad)DarioHealth (DRIO) to Release Earnings on ThursdayMarch 20, 2025 | americanbankingnews.comDarioHealth Appoints New Auditing Firm PwC MemberMarch 14, 2025 | tipranks.comEarnings call transcript: DarioHealth Q4 2024 beats EPS expectationsMarch 12, 2025 | uk.investing.comDarioHealth price target lowered to $2 from $3.50 at StifelMarch 11, 2025 | markets.businessinsider.comDarioHealth Corp. (NASDAQ:DRIO) Q4 2024 Earnings Call TranscriptMarch 11, 2025 | msn.comSee More Headlines DRIO Stock Analysis - Frequently Asked Questions How have DRIO shares performed this year? DarioHealth's stock was trading at $0.7861 at the beginning of 2025. Since then, DRIO shares have decreased by 20.7% and is now trading at $0.6230. View the best growth stocks for 2025 here. How were DarioHealth's earnings last quarter? DarioHealth Corp. (NASDAQ:DRIO) announced its quarterly earnings data on Thursday, November, 7th. The company reported ($0.25) EPS for the quarter, missing the consensus estimate of ($0.18) by $0.07. The firm had revenue of $7.42 million for the quarter, compared to analysts' expectations of $7.34 million. DarioHealth had a negative trailing twelve-month return on equity of 72.16% and a negative net margin of 205.62%. Does DarioHealth have any subsidiaries? The following companies are subsidiaries of DarioHealth: PsyInnovations Inc., Upright Technologies Ltd., Labstyle Innovation Ltd., PsyInnovations India Private Limited., and Upright Technologies Inc.. Who are DarioHealth's major shareholders? Top institutional investors of DarioHealth include Nantahala Capital Management LLC (7.17%), DLK Investment Management LLC (0.42%), LPL Financial LLC (0.34%) and Citadel Advisors LLC. Insiders that own company stock include Erez Raphael and Steven Charles Nelson. View institutional ownership trends. How do I buy shares of DarioHealth? Shares of DRIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of DarioHealth own? Based on aggregate information from My MarketBeat watchlists, some other companies that DarioHealth investors own include NVIDIA (NVDA), Meta Platforms (META), Pfizer (PFE), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM) and Tesla (TSLA). Company Calendar Last Earnings11/07/2024Today3/29/2025Next Earnings (Estimated)5/13/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:DRIO CIK1533998 Webwww.mydario.com Phone(833) 914-3796Fax972-4770-4059Employees200Year Founded2011Price Target and Rating Average Stock Price Target$1.50 High Stock Price Target$2.00 Low Stock Price Target$1.00 Potential Upside/Downside+140.8%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.62) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-59,430,000.00 Net Margins-205.62% Pretax Margin-214.05% Return on Equity-72.16% Return on Assets-40.74% Debt Debt-to-Equity Ratio0.35 Current Ratio1.57 Quick Ratio1.32 Sales & Book Value Annual Sales$27.04 million Price / Sales0.96 Cash FlowN/A Price / Cash FlowN/A Book Value$2.14 per share Price / Book0.29Miscellaneous Outstanding Shares41,567,000Free Float28,470,000Market Cap$25.90 million OptionableOptionable Beta1.42 Social Links The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:DRIO) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredCrypto Genius: 12,000% in 12 months? [Here’s how]We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredForget Trump’s Tariffs, This March Event Is BiggerWhile everyone is distracted by Trump’s tariffs and a potential trade war… There’s something much bigger ha...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DarioHealth Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share DarioHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.